Tech Company Financing Transactions

Outpace Bio Funding Round

On 4/1/2021, Outpace Bio raised $30 million in Series A funding from ARTIS Ventures, Lyell Immunopharma and Abstract Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

500 Fairview Ave. N. 560
Seattle, WA 98109
USA

Phone

Undisclosed

Website

www.outpacebio.com

Email Address

Not Recorded

Overview

Outpace is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming. Outpace is combining the design of improved biological functions and cellular control modalities to harness the full complexity of cellular biology to tackle incurable disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Marc Lajoie

        

Chief Scientific Officer

Scott Boyken

        

Browse more venture capital transactions:

Prev: 4/1/2021: Elevate K-12 venture capital transaction
Next: 4/1/2021: Awkward Essentials venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to record all VC transactions involving tech companies. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary